Contract Deobligations Alert — July 23, 2026

Booz Allen Hamilton secured a $1.07B defense contract from GSA, the largest award in this digest at 83% of total obligations. The lack of competition details suggests a sole-source or highly specialized award, signaling a strong competitive moat in defense advisory services.

Air Products won a firm-fixed-price delivery order from NASA for helium support at Kennedy Space Center, with a total potential value of $172.0M including options. The contract runs through September 2025, providing stable annual revenue of ~$24.1M and high payment certainty with $120.2M already outlayed.

IAVI's $95.6M firm-fixed-price contract for Marburg and Sudan ebolavirus vaccine development transfers cost overrun risk to the nonprofit, with only $47.3M outlayed. The R&D nature (NAICS 541714) means technical milestones are critical for continued funding, and IAVI's nonprofit status limits direct equity upside for public investors.

Booz Allen Hamilton's $1.07B contract lacks pricing and competition details, creating uncertainty about whether it is fixed-price (higher risk) or cost-plus (lower risk). If fixed-price, cost overruns could pressure margins.

IAVI's $95.6M BARDA contract is firm-fixed-price for R&D, transferring cost overrun risk to the nonprofit. IAVI has limited financial buffers compared to for-profit biotechs, increasing the risk of milestone delays or funding shortfalls.

NASA's $120.3M helium contract to Air Products runs through September 2025, but future option exercises depend on NASA's budget for space launch operations. A Continuing Resolution or budget cuts could delay or reduce follow-on orders.

Booz Allen Hamilton's $1.07B award represents 83% of total digest value, indicating high concentration risk for the firm if this contract faces protest or re-compete challenges.

Booz Allen Hamilton's $1.07B defense contract signals continued DOD spending on consulting and advisory services, creating follow-on opportunities for the firm and peers like CACI, Leidos, and SAIC in defense IT and mission support.

Air Products' $120.3M NASA helium contract supports growing space launch infrastructure demand at Kennedy Space Center, with potential for additional orders as NASA's Artemis program and commercial launches increase.

BARDA's $166.9M total contract value for filovirus vaccines signals sustained government investment in biodefense R&D, creating opportunities for biotech firms with pandemic preparedness capabilities.

Booz Allen Hamilton's $1.07B award, the largest in this digest, underscores DOD's reliance on specialized consulting for mission-critical programs. This aligns with sustained defense budgets and NDAA priorities for modernization.

Air Products' $120.3M helium contract for Kennedy Space Center highlights NASA's ongoing need for propellant and support gases as space launch activity increases. This supports a bullish outlook for industrial gas suppliers with government aerospace exposure.

IAVI's $166.9M total contract for filovirus vaccines demonstrates HHS/BARDA's continued commitment to pandemic preparedness, even as broader government budgets face CR risks. This supports a stable outlook for biotech firms in biodefense.

{"entity" => "Booz Allen Hamilton", "reason" => "The $1.07B defense contract lacks pricing and competition details, creating uncertainty about margin impact and protest risk.", "trigger" => "Contract modification disclosures or GAO protest filings"}

{"entity" => "Air Products and Chemicals", "reason" => "The $120.3M NASA helium contract has $120.2M already outlayed, but future option exercises depend on NASA budget stability.", "trigger" => "NASA budget appropriations for FY2025 or option exercise announcements"}

{"entity" => "IAVI Inc.", "reason" => "The $95.6M BARDA contract carries high execution risk due to firm-fixed-price R&D structure and nonprofit status.", "trigger" => "Technical milestone announcements or BARDA option exercise decisions"}

{"entity" => "Defense consulting sector", "reason" => "Booz Allen's $1.07B award signals continued DOD spending, but re-compete risk for large contracts could impact peers.", "trigger" => "GSA re-compete announcements or NDAA provisions affecting consulting spending"}